f Is Oxidized Low-Density Lipoprotein a Principal Actor in Atherogenesis?

References

1. SahebkarA. KianiZ. RouhaniM.H. MahdaviA. AskariG. JamialahmadiT. BagherniyaM. The effect of probiotics on oxidized LDL levels: A systematic review and meta-analysis of clinical trials.Curr. Med. Chem.2023[Ahead of Print].10.2174/0929867331666230815104548 37581525
   [Google Scholar]
2. SteinbergD. Low density lipoprotein oxidation and its pathobiological significance.J. Biol. Chem.199727234209632096610.1074/jbc.272.34.20963 9261091
   [Google Scholar]
3. PalinskiW. RosenfeldM.E. Ylä-HerttualaS. GurtnerG.C. SocherS.S. ButlerS.W. ParthasarathyS. CarewT.E. Stein-bergD. WitztumJ.L. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci.19898641372137610.1073/pnas.86.4.1372 2465552
   [Google Scholar]
4. OrekhovA.N. TertovV.V. KabakovA.E. Adamova IYu; Pokrovsky, S.N.; Smirnov, V.N. Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation.Arterioscler. Thromb.199111231632610.1161/01.ATV.11.2.316 1998649
   [Google Scholar]
5. AvogaroP. BonG.B. CazzolatoG. Presence of a modified low density lipoprotein in humans.Arteriosclerosis198881798710.1161/01.ATV.8.1.79 3341993
   [Google Scholar]
6. KraussR.M. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk.Curr. Opin. Lipidol.19945533934910.1097/00041433‑199410000‑00005 7858908
   [Google Scholar]
7. TertovV.V. SobeninI.A. GabbasovZ.A. PopovE.G. JaakkolaO. SolakiviT. NikkariT. SmirnovV.N. OrekhovA.N. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.Lab. Invest.1992675665675 1434544
   [Google Scholar]